Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "presynaptic glutamate release machinery" refers to the multi-protein complex at the presynaptic terminal of glutamatergic neurons responsible for the docking, priming, and fusion of synaptic vesicles with the plasma membrane to allow calcium-dependent exocytosis of glutamate into the synaptic cleft. Key components include SNARE proteins (such as synaptobrevin, syntaxin, and SNAP-25), calcium sensors (such as synaptotagmin), and other regulatory/adaptor proteins that organize vesicle pools and control their readiness for neurotransmitter release. The machinery is essential for reliable synaptic transmission, synaptic plasticity, and normal brain function. Its dysfunction is implicated in a range of neurological and neuropsychiatric disorders.
Inhibition or modulation of protein-protein interactions (e.g., SNARE complex inhibition); Manipulation of synaptic vesicle release probability (e.g., via presynaptic ion channel modulation)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Presynaptic glutamate release machinery.